Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard R Mellor

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Biochemical and Biophysical Research Communications|February 1, 2002
Modulation of THP-1 macrophage and cholesterol-loaded foam cell apolipoprotein E levels by glycosphingolipidsBrett Garner, Howard R Mellor, Terry D Butters, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|June 14, 2003
Small-molecule therapeutics for the treatment of glycolipid lysosomal storage disordersTerry D Butters, Howard R Mellor, Keishi Narita, et al.
Biochemical Pharmacology|January 27, 2010
Synchronised phosphorylation of BNIP3, Bcl-2 and Bcl-xL in response to microtubule-active drugs is JNK-independent and requires a mitotic kinaseHoward R Mellor, Kasper M Rouschop, Simon M Wigfield, et al.
American Journal of Physiology. Cell Physiology|March 12, 2020
Hydrostatic pressure regulates CYP1A2 expression in human hepatocytes via a mechanosensitive aryl hydrocarbon receptor-dependent pathwayLewis Burton, Paula Scaife, Stuart W Paine, et al.
Cancer Research|May 7, 2009
The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with BortezomibManuela Milani, Tomasz Rzymski, Howard R Mellor, et al.
Drug Discovery Today|November 26, 2013
Reducing attrition in drug development: smart loading preclinical safety assessmentRuth A Roberts, Stefan L Kavanagh, Howard R Mellor, et al.
The Biochemical Journal|May 7, 2004
Cellular effects of deoxynojirimycin analogues: uptake, retention and inhibition of glycosphingolipid biosynthesisHoward R Mellor, David C A Neville, David J Harvey, et al.
The Biochemical Journal|May 7, 2004
Cellular effects of deoxynojirimycin analogues: inhibition of N-linked oligosaccharide processing and generation of free glucosylated oligosaccharidesHoward R Mellor, David C A Neville, David J Harvey, et al.
Journal of the American Chemical Society|October 13, 2007
Elemental tomography of cancer-cell spheroids reveals incomplete uptake of both platinum(II) and platinum(IV) complexesRebecca A Alderden, Howard R Mellor, Szabolcs Modok, et al.
The Biochemical Journal|May 2, 2002
Preparation, biochemical characterization and biological properties of radiolabelled N-alkylated deoxynojirimycinsHoward R Mellor, James Nolan, Lea Pickering, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Biochemical and Biophysical Research Communications|February 1, 2002
Modulation of THP-1 macrophage and cholesterol-loaded foam cell apolipoprotein E levels by glycosphingolipidsBrett Garner, Howard R Mellor, Terry D Butters, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|June 14, 2003
Small-molecule therapeutics for the treatment of glycolipid lysosomal storage disordersTerry D Butters, Howard R Mellor, Keishi Narita, et al.
Biochemical Pharmacology|January 27, 2010
Synchronised phosphorylation of BNIP3, Bcl-2 and Bcl-xL in response to microtubule-active drugs is JNK-independent and requires a mitotic kinaseHoward R Mellor, Kasper M Rouschop, Simon M Wigfield, et al.
American Journal of Physiology. Cell Physiology|March 12, 2020
Hydrostatic pressure regulates CYP1A2 expression in human hepatocytes via a mechanosensitive aryl hydrocarbon receptor-dependent pathwayLewis Burton, Paula Scaife, Stuart W Paine, et al.
Cancer Research|May 7, 2009
The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with BortezomibManuela Milani, Tomasz Rzymski, Howard R Mellor, et al.
Drug Discovery Today|November 26, 2013
Reducing attrition in drug development: smart loading preclinical safety assessmentRuth A Roberts, Stefan L Kavanagh, Howard R Mellor, et al.
The Biochemical Journal|May 7, 2004
Cellular effects of deoxynojirimycin analogues: uptake, retention and inhibition of glycosphingolipid biosynthesisHoward R Mellor, David C A Neville, David J Harvey, et al.
The Biochemical Journal|May 7, 2004
Cellular effects of deoxynojirimycin analogues: inhibition of N-linked oligosaccharide processing and generation of free glucosylated oligosaccharidesHoward R Mellor, David C A Neville, David J Harvey, et al.
Journal of the American Chemical Society|October 13, 2007
Elemental tomography of cancer-cell spheroids reveals incomplete uptake of both platinum(II) and platinum(IV) complexesRebecca A Alderden, Howard R Mellor, Szabolcs Modok, et al.
The Biochemical Journal|May 2, 2002
Preparation, biochemical characterization and biological properties of radiolabelled N-alkylated deoxynojirimycinsHoward R Mellor, James Nolan, Lea Pickering, et al.
Pageof 3